Gastroenteritis refers to the inflammation of the stomach, small intestine, and large intestine. The primary cause of acute gastrointestinal illnesses (AGI) is viral infections, particularly Norovirus and Rotavirus, while bacterial pathogens like Clostridioides difficile (C. difficile) can also be responsible. C. difficile is an anaerobic bacterium found widely in soil and the intestinal tracts of animals. The clinical spectrum of C. difficile infection (CDI) varies from mild diarrhoea to severe and life-threatening pseudomembranous colitis. Transmission mainly occurs within healthcare settings such as hospitals, through patient-to-patient contact, contaminated hands of healthcare workers, or environmental contamination.
The Vivalytic C. difficile panel is specifically designed to detect the presence of Clostridioides difficile toxin genes tcdA and tcdB from liquid or soft human stool samples to enhance healthcare practices. With its advanced capabilities, this diagnostic tool empowers healthcare providers in their efforts to combat C. difficile infections, contributing to more effective management of this challenging condition.
Key Benefits:
- Quick turnaround time of less than 50 minutes, beneficial for both the patient and for the containment of C.difficile
- Convenient 4 step process from sample entry to results. Suitable for use in laboratory and non-laboratory settings
- Detection from liquid or soft human stool specimens